CN Patent

CN115554238A — 眼用混悬液及其制备方法

Assigned to Suzhou Aokangweishi Biotechnology Co ltd · Expires 2023-01-03 · 3y expired

What this patent protects

本发明涉及眼科药物技术领域，具体而言，涉及一种眼用混悬液及其制备方法。该眼用混悬液包含i)活性成份颗粒，所述活性成份颗粒以治疗有效量存在且粒径≤1.5μm，ii)0.1w/w％～1.0w/w％助悬剂，和iii)所述活性成份颗粒难溶的水性溶剂。

USPTO Abstract

本发明涉及眼科药物技术领域，具体而言，涉及一种眼用混悬液及其制备方法。该眼用混悬液包含i)活性成份颗粒，所述活性成份颗粒以治疗有效量存在且粒径≤1.5μm，ii)0.1w/w％～1.0w/w％助悬剂，和iii)所述活性成份颗粒难溶的水性溶剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN115554238A
Jurisdiction
CN
Classification
—
Expires
2023-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Aokangweishi Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.